Home›Stock Screener›Cian Healthcare›Quarterly Results

Cian Healthcare Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹-26 Cr
QMarch 2025
Quarterly Results

In 2026, Cian Healthcare (CHCL) reported revenue ₹0 Cr and net profit ₹0 Cr. Compare with Cian Healthcare value estimation to assess whether the stock is under or overvalued.

CHCL Quarterly Results — Revenue, Profit & EPS Highlights

Cian Healthcare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit CHCL share price.

  • Revenue of ₹31 Cr in March 2025 (+0.0% vs March 2025, -50.0% vs March 2024)
  • Net Profit of ₹-26 Cr in March 2025 (+0.0% vs March 2025, -2700.0% vs March 2024)
  • EBITDA of ₹-6 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of -22.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹-10.39 in March 2025 (+0.0% vs March 2025)

Cian Healthcare Quarterly Results — Revenue, EBITDA, Net Profit & EPS

CHCL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 0 31 62 69 78 - -
Net Profit (₹ Cr) 0 -26 1 2 -6 - -
EBITDA (₹ Cr) 0 -6 11 13 5 - -
EPS (₹) 0.00 -10.39 0.34 0.81 -2.21 - -
Operating Margin (%) 0.0% -22.0% 18.0% 18.0% 5.0% - -

CHCL Share Price Trend — 1-Year Movement Across Quarterly Results

Cian Healthcare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore CHCL share price charts to track price trends across different timeframes.

Profitability Ratios

Profit Margin -83.9%
EBITDA Margin -19.4%
Operating Margin -22.0%
ROE (Annual) -81.3%

Balance Sheet Highlights

Total Assets ₹156 Cr
Total Equity ₹32 Cr
Current Assets ₹71 Cr
Current Liabilities ₹9 Cr

Cash Flow Analysis

Operating Cash Flow ₹21 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹-4 Cr
Net Cash Flow ₹17 Cr

Revenue Trend (₹ Cr)

March 2023 69
March 2024 62
March 2025 31
2026 0

Net Profit Trend (₹ Cr)

March 2023 2
March 2024 1
March 2025 -26
2026 0

Operating Margin Trend (%)

March 2023 18.0%
March 2024 18.0%
March 2025 -22.0%
2026 0.0%

CHCL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Cian Healthcare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹442,581.33 Cr 1844.6 15,018 2,710 +1.0% +11.8% 18.0% 163.2
Divis Laboratories
Sept 2025 		₹179,470.03 Cr 6887.0 2,860 689 +7.1% - 24.1% 265.2
Torrent Pharmaceuti…
Mar 2026 		₹151,833.39 Cr 4486.2 4,111 364 +27.7% +42.2% 8.9% 389.8
Cipla
Mar 2026 		₹113,024.67 Cr 1399.2 6,612 543 -14.3% -4.0% 8.2% 203.7
Dr Reddys Laborator…
Mar 2026 		₹109,104.54 Cr 1307.2 7,996 221 -12.5% -11.5% 2.8% 493.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores